These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance]. Nakamura T Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380 [No Abstract] [Full Text] [Related]
9. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance]. Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458 [TBL] [Abstract][Full Text] [Related]
10. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Juhan-Vague I; Alessi MC; Morange PE Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987 [TBL] [Abstract][Full Text] [Related]
11. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171 [TBL] [Abstract][Full Text] [Related]
12. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease. Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512 [TBL] [Abstract][Full Text] [Related]
14. Type II diabetes and syndrome X. Pathogenesis and glycemic management. Karam JH Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069 [TBL] [Abstract][Full Text] [Related]